Article

Identification of Immunodominant T-lymphocyte Epitope Peptides in HPV 1, 2 and 3 L1 Protein for Novel Cutaneous Wart Vaccine

2021-09-24

Abstract excerpt

<h4>Background</h4> Common warts and flat warts are caused by the human papillomavirus (HPV). Peak incidence of wart infection occurs in schoolchildren aged 12-16, where prevalence can be as high as 20%. Traditional treatments aimed at destruction of wart tissue have low clearance rates and high recurrence rates. Occasional reports have even shown warts becoming malignant and progressing into verrucous carcinoma....

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 10ddf303-4e6e-57db-8031-eb5076aa2ef1
DOI: 10.1101/2021.09.24.461620

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Identification of Immunodominant T-lymphocyte Epitope Peptides in HPV 1, 2 and 3 L1 Protein for Novel Cutaneous Wart VaccineDOI 10.1101/2021.09.24.461620Read

Designing and immunomolecular analysis of a new broad-spectrum multiepitope vaccine against divergent human papillomavirus typesSemantic proximity Read

HPV T-cell epitope landscape: systematic mapping of distribution, conservation, and HLA promiscuity towards rational vaccine designSemantic proximity Read

Rational Design of Peptide Vaccines against Multiple Types of Human PapillomavirusSemantic proximity Read

In silico/In vivo analysis of high-risk papillomavirus L1 and L2 conserved sequences for development of cross-subtype prophylactic vaccineSemantic proximity Read

Virus-like Particle-Based L2 Vaccines against HPVs: Where Are We Today?Semantic proximity Read

Computational formulation of a multiepitope vaccine unveils an exceptional prophylactic candidate against Merkel cell polyomavirusSemantic proximity Read

Progress in L2-Based Prophylactic Vaccine Development for Protection against Diverse Human Papillomavirus Genotypes and Associated DiseasesSemantic proximity Read

A candidate multi‐epitope vaccine against Lumpy skin diseaseSemantic proximity Read

A comprehensive in silico analysis for identification of therapeutic epitopes in HPV16, 18, 31 and 45 oncoproteinsSemantic proximity Read

Potential of Recombinant Chimeric HPV16 L1/L2 VLPs Produced by Distinct Cell Lineages Such as Prophylactic Nanovaccine and Therapeutic Drug NanocarriersSemantic proximity Read

Cytotoxic T-cell-based vaccine against SARS-CoV2: a hybrid immunoinformatic approachSemantic proximity Read

In Silico Design and Immunological Studies of Two Novel Multiepitope DNA-Based Vaccine Candidates Against High-Risk Human PapillomavirusesSemantic proximity Read